Phase 1 Study of JLP-2302 and JP-1366: PK and Safety in Healthy Volunteers

Inclusion Criteria: * Subjects with a body mass index (BMI) between 18.0 and 30.0 kg/m² * Subjects without any clinically significant congenital or chronic disease, and with no pathological findings based on medical examination * Subjects who agree to use a medically acceptable method of contraception\* Exclusion Criteria: * Subjects who have taken enzyme-inducing or -inhibiting drugs * Subjects who have participated in a bioequivalence or other clinical trial and received an investigational product within 6 months prior to the first dose * Subjects with a history of gastrointestinal surgery that may affect drug absorption * Subjects with a clinically significant history of psychiatric illness * Female subjects who are pregnant, suspected of being pregnant, or currently breastfeeding